Potential clinical and economic benefits of remote deep brain stimulation programming
Abstract Deep brain stimulation (DBS) teleprogramming may help reducing travel-related and other financial burdens for patients and maintaining DBS care in special situations. To determine travel-related burdens of DBS patients and explore effects of COVID-19 on DBS care. Travel- and visit-related d...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-10-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-022-22206-z |
| _version_ | 1811336526820278272 |
|---|---|
| author | Dávid Pintér Evelyn Járdaházi József Janszky Norbert Kovács |
| author_facet | Dávid Pintér Evelyn Járdaházi József Janszky Norbert Kovács |
| author_sort | Dávid Pintér |
| collection | DOAJ |
| description | Abstract Deep brain stimulation (DBS) teleprogramming may help reducing travel-related and other financial burdens for patients and maintaining DBS care in special situations. To determine travel-related burdens of DBS patients and explore effects of COVID-19 on DBS care. Travel- and visit-related data of 319 patients were retrospectively analyzed for the first year, five years, and ten years after initiating DBS. Frequencies of in-person and telemedicine visits over the 18-month periods just before and after the outbreak of COVID-19 in Hungary were also compared. Average travel distance during an in-person visit was 415.2 ± 261.5 km, while average travel time was 342.1 ± 199.4 min. Travel costs for the first year, five years, and ten years were 151.8 ± 108.7, 461.4 ± 374.6, and 922.7 ± 749.1 Euros, respectively. Travel distance, age, and type and severity of disease could help identify patients who would particularly benefit from teleprogramming. We detected a significant decrease in the number of visits during COVID-19 pandemic (from 3.7 ± 2.1 to 2.4 ± 2.7; p < 0.001) which mainly resulted from the decreased frequency of in-person visits (3.6 ± 2.0 vs. 1.7 ± 1.8; p < 0.001). Our results support the introduction of DBS teleprogramming in Hungary which could save money and time for patients while maintaining a secure delivery of DBS. |
| first_indexed | 2024-04-13T17:40:52Z |
| format | Article |
| id | doaj.art-bd137785b5354277a742e20838109a0a |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-13T17:40:52Z |
| publishDate | 2022-10-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-bd137785b5354277a742e20838109a0a2022-12-22T02:37:11ZengNature PortfolioScientific Reports2045-23222022-10-0112111010.1038/s41598-022-22206-zPotential clinical and economic benefits of remote deep brain stimulation programmingDávid Pintér0Evelyn Járdaházi1József Janszky2Norbert Kovács3Department of Neurology, Medical School, University of PécsDepartment of Neurology, Medical School, University of PécsDepartment of Neurology, Medical School, University of PécsDepartment of Neurology, Medical School, University of PécsAbstract Deep brain stimulation (DBS) teleprogramming may help reducing travel-related and other financial burdens for patients and maintaining DBS care in special situations. To determine travel-related burdens of DBS patients and explore effects of COVID-19 on DBS care. Travel- and visit-related data of 319 patients were retrospectively analyzed for the first year, five years, and ten years after initiating DBS. Frequencies of in-person and telemedicine visits over the 18-month periods just before and after the outbreak of COVID-19 in Hungary were also compared. Average travel distance during an in-person visit was 415.2 ± 261.5 km, while average travel time was 342.1 ± 199.4 min. Travel costs for the first year, five years, and ten years were 151.8 ± 108.7, 461.4 ± 374.6, and 922.7 ± 749.1 Euros, respectively. Travel distance, age, and type and severity of disease could help identify patients who would particularly benefit from teleprogramming. We detected a significant decrease in the number of visits during COVID-19 pandemic (from 3.7 ± 2.1 to 2.4 ± 2.7; p < 0.001) which mainly resulted from the decreased frequency of in-person visits (3.6 ± 2.0 vs. 1.7 ± 1.8; p < 0.001). Our results support the introduction of DBS teleprogramming in Hungary which could save money and time for patients while maintaining a secure delivery of DBS.https://doi.org/10.1038/s41598-022-22206-z |
| spellingShingle | Dávid Pintér Evelyn Járdaházi József Janszky Norbert Kovács Potential clinical and economic benefits of remote deep brain stimulation programming Scientific Reports |
| title | Potential clinical and economic benefits of remote deep brain stimulation programming |
| title_full | Potential clinical and economic benefits of remote deep brain stimulation programming |
| title_fullStr | Potential clinical and economic benefits of remote deep brain stimulation programming |
| title_full_unstemmed | Potential clinical and economic benefits of remote deep brain stimulation programming |
| title_short | Potential clinical and economic benefits of remote deep brain stimulation programming |
| title_sort | potential clinical and economic benefits of remote deep brain stimulation programming |
| url | https://doi.org/10.1038/s41598-022-22206-z |
| work_keys_str_mv | AT davidpinter potentialclinicalandeconomicbenefitsofremotedeepbrainstimulationprogramming AT evelynjardahazi potentialclinicalandeconomicbenefitsofremotedeepbrainstimulationprogramming AT jozsefjanszky potentialclinicalandeconomicbenefitsofremotedeepbrainstimulationprogramming AT norbertkovacs potentialclinicalandeconomicbenefitsofremotedeepbrainstimulationprogramming |